Prime Therapeutics Initiative Aims to Help Plan Sponsors Pay for Gene Therapies
April 13, 2020
The new PreserveRx program from Prime Therapeutics looks to help plan sponsors deal with high-cost gene therapies, Fierce Healthcare reports.
According to the report, members of the new program will pay a monthly fee in order to be protected from the crippling costs of expensive drugs like Zolgensma.
“We want to preserve access to these therapies but at the same time understand that they’re incredibly expensive,” Prime Therapeutics Assistant Vice President of Health Outcomes told Fierce Healthcare.
To read the full report, click here.
